Glen Eagle Advisors, LLC Embecta Corp. Transaction History
Glen Eagle Advisors, LLC
- $593 Billion
- Q3 2024
A detailed history of Glen Eagle Advisors, LLC transactions in Embecta Corp. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 175 shares of EMBC stock, worth $3,645. This represents 0.0% of its overall portfolio holdings.
Number of Shares
175
Previous 175
-0.0%
Holding current value
$3,645
Previous $2.19 Million
12.8%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EMBC
# of Institutions
405Shares Held
51.1MCall Options Held
162KPut Options Held
61K-
Black Rock Inc. New York, NY9.19MShares$192 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$146 Million0.0% of portfolio
-
River Road Asset Management, LLC3.48MShares$72.4 Million0.69% of portfolio
-
American Century Companies Inc Kansas City, MO3.02MShares$62.9 Million0.03% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.73MShares$56.9 Million0.72% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $1.2B
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...